Cardiac rehabilitation program for end-stage heart failure patients with left ventricular assist devices in Hong Kong

被引：0
|
作者：
Fan, K. Y. Y. [1 ]
Wong, K. L. [1 ]
Fu, N. [1 ]
Cheng, K. Y. [1 ]
Chow, Y. M. [1 ]
Au, K. L. [1 ]
Au, W. K. [2 ]
Ho, C. [2 ]
机构：
[1] Grantham Hosp, Cardiac Med Unit, Aberdeen, Hong Kong, Peoples R China
[2] Queen Mary Hosp, Cardiothorac Surg Dept, Hong Kong, Peoples R China
来源：
EUROPEAN HEART JOURNAL | 2020年 / 41卷
关键词：
D O I：
10.1093/ehjci/ehz872.046
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P101
引用
收藏
页码：49 / 49
页数：1
相关论文
共 50 条
  • [41] Ventricular Assist Device Support in End-Stage Heart Failure From Cardiac Amyloidosis
    Lim, Choon Pin
    Lim, Yeong Phang
    Lim, Chong Hee
    Ong, Hean Yee
    Tan, Daryl
    Chew, Huck Chin
    Omar, Abdul Razakjr
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2019, 48 (12) : 435 - 438
  • [42] Development of a Pacemaker with a Ventricular Assist Device for End-Stage Heart Failure Patients
    Kim, Yoo Seok
    Park, Sung Min
    Choi, Seong Wook
    TRANSACTIONS OF THE KOREAN SOCIETY OF MECHANICAL ENGINEERS B, 2011, 35 (11) : 1205 - 1211
  • [43] Ventricular Assist System Applications in End-stage Heart Failure
    Yagdi, T.
    Oguz, E.
    Ayik, F.
    Ertugay, S.
    Nalbantgil, S.
    Engin, C.
    Ozbaran, M.
    TRANSPLANTATION PROCEEDINGS, 2011, 43 (03) : 923 - 926
  • [44] Cost-effectiveness of left ventricular assist devices for patients with end-stage heart failure: analysis of the French hospital discharge database
    Tadmouri, Abir
    Blomkvist, Josefin
    Landais, Cecile
    Seymour, Jerome
    Azmoun, Alexandre
    ESC HEART FAILURE, 2018, 5 (01): : 75 - 86
  • [45] Use of miniaturized extracorporeal circulation for implanting left ventricular assist devices in high-risk end-stage heart failure patients
    P Antonitsis
    H Argiriadou
    P Tossios
    A Deliopoulos
    S Westaby
    K Anastasiadis
    Journal of Cardiothoracic Surgery, 8 (Suppl 1)
  • [46] The apelin receptor mRNA levels and myocardial recovery in end-stage heart failure patients treated with left ventricular assist devices (LVADs)
    Farkasfalvi, Klara
    Felkin, Leanne
    Latif, Najma
    Soppa, Gopal K.
    George, Robert
    Birks, Emma
    Barton, Paul
    Marczin, Nandor
    Yacoub, Magdi H.
    Terracciano, Cesare M.
    CIRCULATION, 2006, 114 (18) : 484 - 484
  • [47] Macrovascular and microvascular function after implantation of left ventricular assist devices in end-stage heart failure: Role of microparticles
    Sansone, Roberto
    Stanske, Beate
    Keymel, Stefanie
    Schuler, Dominik
    Horn, Patrick
    Saeed, Diyar
    Boeken, Udo
    Westenfeld, Ralf
    Lichtenberg, Artur
    Kelm, Make
    Heiss, Christian
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (07): : 921 - 932
  • [48] Hypomagnesemia after heart transplantation or left ventricular assist device implant for end-stage heart failure
    Racca, Vittorio
    Scaglione, Anna
    De Maria, Renata
    Panzarino, Claudia
    Santangelo, Maria Antonia
    Cipriani, Manlio
    CLINICAL TRANSPLANTATION, 2020, 34 (08)
  • [49] Clinical Implications of Respiratory Failure in Patients Receiving Durable Left Ventricular Assist Devices for End Stage Heart Failure
    Miller, P. Elliott
    Caraballo, Cesar
    Ravindra, Neal G.
    Mezzacappa, Catherine
    McCullough, Megan
    Gruen, Jadry
    Levin, Andrew
    Reinhardt, Samuel
    Ali, Ayyaz
    Desai, Nihar R.
    Ahmad, Tariq
    CIRCULATION, 2019, 140
  • [50] Cardiac molecular markers of programmed cell death are activated in end-stage heart failure patients supported by left ventricular assist device
    Prescimone, Tommaso
    Masotti, Silvia
    D'Amico, Andrea
    Caruso, Raffaele
    Cabiati, Manuela
    Caselli, Chiara
    Viglione, Federica
    Verde, Alessandro
    Del Ry, Silvia
    Giannessi, Daniela
    CARDIOVASCULAR PATHOLOGY, 2014, 23 (05) : 272 - 282
12345